On this page
Ustekinumab is a biologic medicine for Crohn's disease (CD) and ulcerative colitis (UC). It works in a different way from the anti-TNF medicines, so it is often used when they haven't worked or aren't suitable. Many people like it because, after the first dose, the injections are needed only every two or three months.
What is it and how does it work?
Ustekinumab is an antibody, made in the laboratory, that blocks two chemical messengers called interleukin-12 (IL-12) and interleukin-23 (IL-23). Both help to drive the inflammation of inflammatory bowel disease (IBD).
The original brand is Stelara. Biosimilars (versions made by other companies after the patent ended, which work just as well) are now available, and many people in the UK are treated with one of them.
What is it used for?
- Moderate to severe CD or UC that hasn't responded to, or can't be treated with, steroids, immunosuppressants or an anti-TNF medicine such as infliximab or adalimumab.
- It is sometimes chosen as the first biologic, for example for people at higher risk of infections or with psoriasis, which it also treats.
Before you start
You will have blood tests, including checks for tuberculosis (TB), hepatitis B and C and HIV, and your vaccinations will be reviewed. Tell your team if you have an infection or have had cancer.
How is it given?
- First dose: a single drip (infusion) into a vein in hospital, lasting about an hour. The dose depends on your weight.
- Then: an injection under the skin 8 weeks later, followed by an injection every 12 weeks, or every 8 weeks if needed to keep your IBD under control.
You can learn to inject yourself at home, and the injections are delivered by a homecare company. Keep them in the fridge.
Some people feel better within a few weeks of the first dose, but it can take up to 16 weeks to see the full effect. If it isn't working well enough, your team may give the injections more often or give an extra dose.
Side effects
Most people have few or no side effects. The more common ones are:
- Colds, sore throat and sinus infections
- Headache and tiredness
- Redness, itching or pain where you inject
- Joint or back pain
Infections. Serious infections are uncommon, but ustekinumab can make it harder to fight some infections. Contact your team or GP if you have a fever or feel unwell, and tell them you take ustekinumab.
Rarely: allergic reactions, and skin problems such as peeling or a widespread rash. Contact your team straight away if you develop a severe rash.
Ustekinumab has been used for many years for psoriasis as well as IBD, and so far it has not been linked to a raised risk of cancer, but your team will keep this under review.
Vaccinations
Don't have live vaccines while taking ustekinumab, unless your specialist advises otherwise. These include yellow fever, oral typhoid and MMR. Non-live vaccines are safe and recommended, including the yearly flu injection, COVID-19, pneumococcal and the non-live shingles vaccine.
Pregnancy and breastfeeding
There is less experience of ustekinumab in pregnancy than of anti-TNF medicines, but the information so far is reassuring. The patient leaflet advises using effective contraception during treatment and for 15 weeks afterwards; in practice, many specialists continue ustekinumab in pregnancy when it is keeping IBD under control, because a flare-up is a greater risk to mother and baby. If you are planning a pregnancy, or become pregnant, talk to your IBD team. If you take it in pregnancy, tell the baby's GP and health visitor, as some live vaccines may need to be delayed. Small amounts pass into breast milk; discuss breastfeeding with your team.
See Pregnancy and Inflammatory Bowel Disease.
Surgery, dental work and travel
Tell your surgeon or dentist that you take ustekinumab before any procedure. Because the injections are spaced out, travel is usually easy to plan around them. See Travel Insurance with Crohn's or Colitis.
If ustekinumab does not work
Your team may shorten the gap between injections, or switch you to another medicine, such as risankizumab, vedolizumab, an anti-TNF or a tablet such as upadacitinib. See Medicines for Crohn's Disease and Ulcerative Colitis.
Never stop ustekinumab without discussing it with your IBD team first.